Bucharest
Hover your mouse on bar for detailed data.
PLHIV Diagnosed
N/A
PLHIV Diagnosed on ART
N/A
PLHIV on ART Virally Suppressed
N/A
PLHIV Diagnosed
N/A
PLHIV on ART
N/A
PLHIV Virally Suppressed
N/A
HIV prevalence among MSM (2014)
Proportion of known HIV positive MSM who are on ART (2014)
Percentage of MSM tested for HIV (2014)
Hover your mouse on bar for detailed data.
MethodologyPLHIV diagnosed and PLHIV treated: The first two stages of the HIV care continuum on the proportion of PLHIV with HIV diagnosis and treatment were derived from the RKI HIV estimates on PLHIV.
PLHIV with viral suppression: For the estimation of the number of people achieving viral suppression we analyzed data from two large German cohort studies, the ClinSurv HIV and the HIV-1 Seroconverter cohort both under the directive of the Robert Koch Institute. Cohort data from 1997-2015 was included in the analysis. For the analysis of persistent viraemia in the study population we developed a 10- day grid model to close gaps between documented viral load (VL) measurements. A period of 180 days was determined as time between ART initiation and viral suppression (VL<50 copies/ml). Persistent viraemia was defined as two consecutive VL measurements >50 copies/ml within 180 days or one VL measurement >1000 copies/ml
Note: Data refer to infections acquired in Germany
Hover your mouse on bar for detailed data.
Data Source: Eckdaten der Schätzung, Robert Koch Institute, 2016
Hover on line for detailed data.
Hover on pie for detailed data.
Hover on bar for detailed data.
© International Association of Providers of AIDS Care. All Rights Reserved. This webportal was developed through a partnership between IAPAC and Dure Technologies, and produced with financial support from multiple donors, none of which had any editorial input or control over its content.